Otsuka America Pharmaceutical clinical trials
A country office of Otsuka Holdings Co., Ltd.
The registry lists 10 studies whose lead sponsor is Otsuka America Pharmaceutical. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated May 15, 2015.
Status
- Completed
- 10
Registry sponsor names on this page
- Otsuka America Pharmaceutical10 studies
Something wrong with this grouping? Tell us on the Otsuka Holdings Co., Ltd. page.
Studies
Recruiting first, then most recently updated. Showing 10 of 10. All Otsuka Holdings Co., Ltd. studies →
- Hyponatremia Registry for Patients With Euvolemic and Hypervolemic HyponatremiaCompletedNCT01240668
Sponsor listed in the registry: Otsuka America Pharmaceutical
- POCone-UBiT-IR300 Pediatric Comparison StudyCompletedNCT01623154Phase 4
Sponsor listed in the registry: Otsuka America Pharmaceutical
- Study for the Treatment of Crohn's Disease With AdacolumnCompletedNCT00162942Phase 3
Sponsor listed in the registry: Otsuka America Pharmaceutical
- Study for the Treatment of Ulcerative Colitis With AdacolumnCompletedNCT00102193Phase 3
Sponsor listed in the registry: Otsuka America Pharmaceutical
- Safety and Efficacy of Pletal (Cilostazol) for the Treatment of Juvenile Primary and Secondary Raynaud's PhenomenonCompletedNCT00048776Phase 4
Sponsor listed in the registry: Otsuka America Pharmaceutical
- Safety and Efficacy of Pletal(Cilostazol) for the Treatment of Juvenile Primary and Secondary Raynaud's PhenomenonCompletedNCT00048763Phase 4
Sponsor listed in the registry: Otsuka America Pharmaceutical
- A Pilot Study of OPC-8212 (Vesnarinone) in Persons With AIDS-Related Kaposi's SarcomaCompletedNCT00002131Phase 2
Sponsor listed in the registry: Otsuka America Pharmaceutical
- A Phase I Study of Three Doses of OPC-8212 (Vesnarinone) in HIV-Infected Persons With CD4+ Cell Number > 300 Cells/mm3CompletedNCT00002129Phase 1
Sponsor listed in the registry: Otsuka America Pharmaceutical
- A Long-Term, Follow-On Safety Study of Four Doses of OPC-8212 (Vesnarinone) in HIV-Infected PersonsCompletedNCT00002130Not applicable
Sponsor listed in the registry: Otsuka America Pharmaceutical
- A Study of Multiple Doses of Vesnarinone in Advanced HIV DiseaseCompletedNCT00002337Phase 1
Sponsor listed in the registry: Otsuka America Pharmaceutical